PRELUDE CAPITAL MANAGEMENT, LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$1,000
-99.5%
200
-99.1%
0.00%
-100.0%
Q2 2019$194,000
-65.1%
23,328
-58.3%
0.01%
-67.7%
Q1 2019$556,000
+134.6%
55,906
+80.1%
0.03%
+93.8%
Q4 2018$237,000
+717.2%
31,034
+1792.3%
0.02%
+700.0%
Q3 2018$29,000
-96.2%
1,640
-97.9%
0.00%
-95.8%
Q2 2018$755,00079,5120.05%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 250,000$1,720,0003.11%
Sio Capital Management, LLC 754,759$5,193,0001.67%
APIS CAPITAL ADVISORS, LLC 90,000$619,0000.97%
KNOTT DAVID M 218,102$1,501,0000.63%
Park West Asset Management LLC 1,747,507$12,023,0000.59%
ArrowMark Colorado Holdings LLC 8,131,528$55,945,0000.56%
DAFNA Capital Management LLC 209,200$1,439,0000.54%
Rubric Capital Management LP 660,000$4,541,0000.42%
Rubric Capital Management LP 500,000$3,440,0000.32%
Cornerstone Capital, Inc. 248,125$1,707,0000.27%
View complete list of VIKING THERAPEUTICS INC shareholders